|
1.
|
Gan SI, Edwards AL, Symonds CJ and Beck
PL: Hypertriglyceridemia-induced pancreatitis: A case-based review.
World J Gastroentrol. 12:7197–7202. 2006.PubMed/NCBI
|
|
2.
|
Dubuquoy L, Rousseaux C, Thuru X, et al:
PPARgamma as a new therapeutic in inflammatory bowel diseases. Gut.
55:1341–1349. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Kapadia R, Yi JH and Vemuganti R:
Mechanisms of anti-inflammatory and neuroprotective actions of
PPAR-gamma agonists. Front Biosci. 13:1813–1826. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Chawla A, Schwarz EJ, Dimaculangan DD and
Lazar MA: Peroxisome proliferator-activated receptor (PPAR) gamma:
adipose-predominant expression and induction early in adipocyte
differentiation. Endocrinology. 135:798–800. 1994.
|
|
5.
|
Nolan JJ, Ludvik B, Beerdsen P, Joyce M
and Olefsky J: Improvement in glucose tolerance and insulin
resistance in obese subjects treated with troglitazone. New Engl J
Med. 331:1188–1193. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Lehrke M and Lazar MA: The many faces of
PPARgamma. Cell. 123:993–999. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Zhang Q, Hu W, Meng B and Tang T: PPARγ
agonist rosiglitazone is neuroprotective after traumatic spinal
cord injury via anti-inflammatory in adult rats. Neurol Res.
32:852–859. 2010.
|
|
8.
|
Esposito E and Cuzzocrea S: Targeting the
peroxisome proliferator-activated receptors (PPARs) in spinal cord
injury. Expert Opin Ther Targets. 15:943–959. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Di Paola R, Mazzon E, Maiere D, et al:
Rosiglitazone reduces the evolution of experimental periodontitis
in the rat. J Dent Res. 85:156–161. 2006.PubMed/NCBI
|
|
10.
|
Cuzzocrea S, Pisano B, Dugo L, et al:
Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of
the peroxisome proliferator-activated receptor-gamma (PPAR-gamma),
reduce ischaemia/reperfusion injury of the gut. Br J Pharmacol.
140:366–376. 2003.
|
|
11.
|
Paszkowski AS, Rau B, Mayer JM, Möller P
and Beger HG: Therapeutic application of caspase
1/interleukin-1beta-converting enzyme inhibitor decreases the death
rate in severe acute experimental pancreatitis. Ann Surg.
235:68–76. 2002. View Article : Google Scholar
|
|
12.
|
Bjelik A, Bereczki E, Gonda S, et al:
Human apoB overexpression and a high-cholesterol diet differently
modify the brain APP metabolism in the transgenic mouse model of
atherosclerosis. Neurochem Int. 49:393–400. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Grewal HP, Mohey el Din A, Gaber L, Kotb M
and Gaber AO: Amelioration of the physiologic and biochemical
changes of acute pancreatitis using an anti-TNF-alpha polyclonal
antibody. Am J Surg. 167:214–219. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Werner J, Z’graggen K, Fernández-del
Castillo C, et al: Specific therapy for local and systemic
complications of acute pancreatitis with monoclonal antibodies
against ICAM-1. Ann Surg. 229:834–842. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Saharia P, Margolis S, Zuidema GD and
Cameron JL: Acute pancreatitis with hyperlipidemia: Studies with an
isolated perfused canine pancreas. Surgery. 82:60–67. 1977.
|
|
16.
|
Hofbauer B, Friess H, Weber A, et al:
Hyperlipaemia intensifies the course of acute oedematous and acute
necrotising pancreatitis in the rat. Gut. 38:753–758. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Kimura W and Mössner J: Role of
hypertriglyceridemia in the pathogenesis of experimental acute
pancreatitis in rats. Int J Pancreatol. 20:177–184. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Blanquart C, Barbier O, Fruchart JC,
Staels B and Glineur C: Peroxisome proliferator-activated
receptors: regulation of transcriptional activities and roles in
inflammation. J Steroid Biochem Mol Biol. 85:267–273. 2003.
View Article : Google Scholar
|
|
19.
|
Escher P and Wahli W: Peroxisome
proliferator-activated receptors: insight into multiple cellular
functions. Mutat Res. 448:121–138. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Mrówka P and Głodkowska-Mrówka E:
Structure, function and role of peroxisome proliferator-activated
receptor-gamma-PPARγ. Postepy Bilol Komorki. 38:629–651. 2011.
|
|
21.
|
Sun X, Tang Y, Tan X, et al: Activation of
peroxisome proliferator-activated receptor-γ by rosiglitazone
improves lipid homeostasis at the adipose tissue-liver axis in
ethanol-fed mice. Am J Physiol Gastrointest Liver Physiol.
302:G548–G557. 2012.
|
|
22.
|
Kouidhi S, Seugnet I, Decherf S, Guissouma
H, Elgaaied AB, Demeneix B and Clerget-Friodevaux MS: Peroxisome
proliferator-activated receptor-gamma (PPARgamma) modulates
hypothalamic Trh regulation in vivo. Mol Cell Endocrinol.
317:44–52. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Chen C, Xu S, Wang WX, Ding YM, Yu KH,
Wang B and Chen XY: Rosiglitazone attenuates the severity of sodium
taurocholate-induced acute pancreatitis and pancreatitis-associated
lung injury. Arch Med Res. 40:79–88. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Cai Q and Xu MY: Protective effect of
rosiglitazone against hyperoxia-induced lung injury in neonatal
rats. Zhongguo Dang Dai Er Ke Za Zhi. 14:301–305. 2012.(In
Chinese).
|
|
25.
|
Bassaganya-Riera J, Viladomiu M, Pedragosa
M, et al: Probiotic bacteria produce conjugated linoleic acid
locally in the gut that targets macrophage PPAR γ to suppress
colitis. PLoS One. 7:e312382012.PubMed/NCBI
|
|
26.
|
Buss Zda S, Medeiros YS and Fröde TS:
PPAR-gamma agonist rosiglitazone attenuates the inflammation caused
by carrageenan in the mouse model of pleurisy. Inflammation.
35:280–288. 2012.PubMed/NCBI
|
|
27.
|
Lin TN, Cheung WM, Wu JS, et al:
15d-Prostaglandin J2 protects brain from ischemia-reperfusion
injury. Arterioscl Throm Vasc Biol. 26:481–487. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Inoue K, Takano H, Yanagisawa R, et al:
Effect of 15-deoxy-delta 12,14-prostaglandin J2 on acute lung
injury induced by lipopolysaccharide in mice. Eur J Pharmacol.
481:261–269. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Ricote M, Li AC, Willson TM, Kelly CJ and
Glass CK: The peroxisome proliferator-activated receptor-gamma is a
negative regulator of macrophage activation. Nature. 391:79–82.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Ricote M and Glass CK: PPARs and molecular
mechanisms of transrepression. Biochim Biophys Acta. 1771:926–935.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Lim HA, Lee EK, Kim JM, et al: PPARγ
activation by baicalin suppresses NF-κB-mediated inflammation in
aged rat kidney. Biogerontology. 13:133–145. 2012.
|
|
32.
|
Kelly D, Campbell JI, King TP, et al:
Commensal anaerobic gut bacteria attenuate inflammation by
regulating nuclear-cytoplasmic shuttling of PPAR-gamma and ReIA.
Nat Immunol. 5:104–112. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Babu SK, Puddicombe SM, Arshad HH, et al:
Tumor necrosis factor alpha (TNF-α) autoregulates its expression
and induces adhesion molecule expression in asthma. Clin Immunol.
140:18–25. 2011.
|
|
34.
|
Hsu WY, Chao YW, Tsai YL, et al: Resistin
induces monocyte-endothelial cell adhesion by increasing ICAM-1 and
VCAM-1 expression in endothelial cells via p38MAPK-dependent
pathway. J Cell Physiol. 226:2181–2188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Yang CM, Luo SF, Hsieh HL, et al:
Interleukin-1beta induces ICAM-1 expression enhancing leukocyte
adhesion in human rheumatoid arthritis synovial fibroblasts:
Involvement of ERK, JNK, AP-1, and NF-kappaB. J Cell Physiol.
224:516–526. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Zhang XD, Hou JF, Qin XJ, et al:
Pentoxifylline inhibits intercellular adhesion molecule-1 (ICAM-1)
and lung injury in experimental phosgene-exposure rats. Inhal
Toxicol. 22:889–895. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Bernot D, Peiretti F, Canault M,
Juhan-Vague I and Nalbone G: Upregulation of TNF-alpha-induced
ICAM-1 surface expression by adenylate cyclase-dependent pathway in
human endothelial cells. J Cell Physiol. 202:434–441. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Frossard JL, Saluja A, Bhagat L, et al:
The role of intercellular adhesion molecule 1 and neutrophils in
acute pancreatitis and pancreatitis-associated lung injury.
Gastroenterology. 116:694–701. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Lundberg AH, Granger DN, Russell J, et al:
Temporal correlation of tumor necrosis factor-alpha release,
upregulation of pulmonary ICAM-1 and VCAM-1, neutrophil
sequestration, and lung injury in diet-induced pancreatitis. J
Gastrointest Surg. 4:248–257. 2000. View Article : Google Scholar
|
|
40.
|
Cuzzocrea S, Pisano B, Dugo L, et al:
Rosiglitazone, a ligand of the peroxisome proliferator-activated
receptor-gamma, reduces acute pancreatitis induced by cerulein.
Intensive Care Med. 30:951–956. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Laveda R, Martinez J, Munoz C, et al:
Different profile of cytokine synthesis according to the severity
of acute pancreatitis. World J Gastroenterol. 11:5309–5313.
2005.PubMed/NCBI
|
|
42.
|
Zhang XP, Ye Q, Jiang XG, et al:
Preparation method of an ideal model of multiple organ injury of
rat with severe acute pancreatitis. World J Gastroentrol.
13:4566–4573. 2007.PubMed/NCBI
|
|
43.
|
Gulcubuk A, Altunatmaz K, Sonmez K, et al:
Effects of curcumin on tumour necrosis factor-alpha and
interleukin-6 in the late phase of experimental acute pancreatitis.
J Vet Med A Physiol Pathol Clin Med. 53:49–54. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Gulben K, Ozdemir H, Berberoğlu U, et al:
Melatonin modulates the severity of taurocholate-induced acute
pancreatitis in the rat. Dig Dis Sci. 55:941–946. 2010. View Article : Google Scholar : PubMed/NCBI
|
